Article
A novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity
2025-02-08
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> While chimeric antigen receptor (CAR) T cells have achieved encouraging remission rates in hematological malignancies, they demonstrated limited success in treating Glioblastoma (GBM), particularly due to high intra- and intertumoral heterogeneity. In this study, we identified a relevant and preserved target antigen, Podoplanin (PDPN), and evaluated the potential of a PDPN-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 87d16412-ec07-5e29-9404-8634bb3bab38
- DOI
- 10.1101/2025.02.03.636223
